Structure–Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands-Reference-Cited by-同舟云学术

Structure–Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands

Published:2021-08-17 Issue:16 Volume:64 Page:12132-12151
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Fronik Philipp¹,Poetsch Isabella¹²³,Kastner Alexander¹,Mendrina Theresa²,Hager Sonja²,Hohenwallner Katharina⁴,Schueffl Hemma²^ORCID,Herndler-Brandstetter Dietmar²,Koellensperger Gunda⁴^ORCID,Rampler Evelyn⁴^ORCID,Kopecka Joanna⁵,Riganti Chiara⁵^ORCID,Berger Walter²³^ORCID,Keppler Bernhard K.¹³,Heffeter Petra²³,Kowol Christian R.¹³^ORCID

Affiliation:

1. Faculty of Chemistry, Institute of Inorganic Chemistry, University of Vienna, Waehringer Strasse 42, 1090 Vienna, Austria

2. Institute of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria

3. Research Cluster “Translational Cancer Therapy Research”, 1090 Vienna, Austria

4. Faculty of Chemistry, Institute of Analytical Chemistry, University of Vienna, Waehringer Strasse 38, 1090 Vienna, Austria

5. Department of Oncology, University of Torino, via Santena 5/bis, 10126 Torino, Italy

Funder

??sterreichischen Akademie der Wissenschaften

Austrian Science Fund

Associazione Italiana per la Ricerca sul Cancro

European Cooperation in Science and Technology

Fellinger Cancer Research Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c00770

Reference60 articles.

1. Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

2. Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery

3. Metal Drugs and the Anticancer Immune Response

4. Platinum coordination compounds with potent anticancer activity

5. Resistance against novel anticancer metal compounds: Differences and similarities

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanostructured mesoporous silica carriers for platinum-based conjugates with anti-inflammatory agents;Biomaterials Advances;2024-12

2. What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review;International Journal of Nanomedicine;2024-09

3. Developing a Copper(II) Isopropyl 2-Pyridyl Ketone Thiosemicarbazone Compound Based on the IB Subdomain of Human Serum Albumin–Indomethacin Complex: Inhibiting Tumor Growth by Remodeling the Tumor Microenvironment;Journal of Medicinal Chemistry;2024-03-29

4. Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands;Coordination Chemistry Reviews;2024-02

5. Cytotoxic Pt(ii) complexes containing alizarin: a selective carrier for DNA metalation;Dalton Transactions;2024